Biotechnology Stocks
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1854 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 29.30 USD | -3.71% | -9.18% | -24.78% | +7.56% | 2.30 B USD | ||
| 1863 |  SLS SELLAS Life Sciences Group, Inc. - Common Stock | 11.26 USD | -0.44% | -2.09% | -17.39% | +483.42% | 2.27 B USD | ||
| 1889 |  IMNM Immunome, Inc. - Common Stock | 19.31 USD | +1.10% | -9.47% | -24.83% | +31.54% | 2.19 B USD | ||
| 1894 |  AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.22 USD | +1.31% | +1.00% | +1.57% | +35.96% | 2.16 B USD | ||
| 1899 |  VERA Vera Therapeutics, Inc. - Class A Common Stock | 29.73 USD | -1.72% | -4.59% | -14.67% | -0.03% | 2.14 B USD | ||
| 1910 |  BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 8.29 USD | -1.31% | +2.09% | -1.43% | +13.56% | 2.12 B USD | ||
| 1911 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.95 USD | -7.49% | -5.50% | +25.40% | -34.60% | 2.11 B USD | ||
| 1925 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 18.34 USD | +0.33% | -4.28% | -20.64% | -18.31% | 2.08 B USD | ||
| 1931 |  VCEL Vericel Corporation - Common Stock | 40.05 USD | -1.69% | +0.10% | +3.43% | +10.18% | 2.05 B USD | ||
| 1936 |  PHVS Pharvaris N.V. - Ordinary Shares | 31.12 USD | -1.77% | -0.29% | -17.23% | +38.74% | 2.03 B USD | ||
| 1952 |  MLYS Mineralys Therapeutics, Inc. - Common Stock | 22.38 USD | +1.31% | -6.79% | -27.50% | -44.56% | 1.98 B USD | ||
| 1968 |  FTRE Fortrea Holdings Inc. - Common Stock | 20.37 USD | -0.92% | +3.19% | +24.51% | +87.74% | 1.94 B USD | ||
| 1973 |  SRPT Sarepta Therapeutics, Inc. - Common Stock | 18.21 USD | +4.06% | +2.59% | -16.51% | -21.34% | 1.92 B USD | ||
| 1982 |  AGIO Agios Pharmaceuticals, Inc. - Common Stock | 31.92 USD | +0.41% | -2.74% | -3.68% | -26.43% | 1.91 B USD | ||
| 1990 |  VIR Vir Biotechnology, Inc. - Common Stock | 11.12 USD | -3.47% | -3.72% | +0.72% | +85.95% | 1.88 B USD | ||
| 1992 |  MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.21 USD | -2.96% | -5.38% | +5.87% | +117.17% | 1.87 B USD | ||
| 1996 |  XERS Xeris Biopharma Holdings, Inc. - Common Stock | 10.19 USD | +0.79% | +9.10% | +30.64% | +24.42% | 1.86 B USD | ||
| 2001 |  GPCR Structure Therapeutics Inc - American Depositary Shares | 25.67 USD | -3.79% | -9.29% | -37.74% | -4.00% | 1.83 B USD | ||
| 2005 |  TRVI Trevi Therapeutics, Inc. - Common Stock | 12.83 USD | -2.36% | -11.46% | -21.86% | +28.69% | 1.83 B USD | ||
| 2008 |  XNCR Xencor, Inc. - Common Stock | 24.50 USD | +0.99% | -3.39% | -0.53% | +86.74% | 1.82 B USD |
ニュース Biotechnology Stocks
RBCキャピタル、Rhythm Pharmaceuticalsの「アウトパフォーム」を維持、目標株価を159ドルに引き上げ
RBCキャピタル、Exelixisの「セクター・パフォーム」を維持、目標株価を45ドルに引き下げ
ADCセラピューティクス、1株1.42ドルで1,290万株、1ワラント1.32ドルで4,810万株を取得できるワラント付きで8,660万ドルのPIPE資金調達を発表；ローンおよびロイヤルティ契約の修正も確保
NutriBand、AVERSA乱用防止経皮技術の保護強化を目的として米国特許出願を提出
BioLineRx社、GLIX1を取り上げた2件の抄録が11月12日～15日に開催される神経腫瘍学会年次総会で発表されることを発表
Atrium Therapeutics、5,170,384株および最大1,134,930株を購入可能なプレファンドワラントの私募を1ユニット約7.93ドルで実施、総額5,000万ドルを発表
「ロシア、シベリアで2件目の感染報告を否定」 - Bloomberg
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |